Clinical Trial Update: A Study to Test the Efficacy, Safety, and Pharmacokinetics of Rozanolixizumab in Adult Study Participants With Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis [Phase 2]

View source ↗

Summary

Phase 2 study of Rozanolixizumab in adults with LGI1 autoimmune encephalitis was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lgi1 Autoimmune Encephalitis

Drugs mentioned

• Rozanolixizumab

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis | Phase 2 | Status: TERMINATED | Results posted: 2025-05-31